Robert Lorne Hopfner - Director, 10%+ Owner at Evommune, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director, 10%+ Owner
Issuer Symbol: EVMN on NYSE
All Insider Reports: All Insider Reports

Robert Lorne Hopfner - trading volume in the past year for Evommune, Inc.

	Shares	%	Avg Price	Total $
Buys	+1,000	100%	$17.35	+$17,350
Sells
Net	+1,000	100%		+$17,350

Holdings reported by Robert Lorne Hopfner for Evommune, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	1,632,441	$30,608,268	$18.75	19 Dec 2025	By Pivotal bioVenture Partners Fund I, L.P.
Common Stock	1,441,032	$27,019,350	$18.75	19 Dec 2025	By NFLS Delta III Limited
Common Stock	294,502	$5,521,912	$18.75	19 Dec 2025	By Pivotal bioVenture Partners Fund II, L.P.
Common Stock	4,026	$69,851	$17.35	19 Dec 2025	By Trust
Series A Preferred Stock	0			07 Nov 2025	By NFLS Delta III Limited	Common Stock
Series A Preferred Stock	0			07 Nov 2025	By Pivotal bioVenture Partners Fund I, L.P.	Common Stock
Series B Preferred Stock	0			07 Nov 2025	By NFLS Delta III Limited	Common Stock
Series B Preferred Stock	0			07 Nov 2025	By Pivotal bioVenture Partners Fund I, L.P.	Common Stock
Series C Preferred Stock	0			07 Nov 2025	By NFLS Delta III Limited	Common Stock
Series C Preferred Stock	0			07 Nov 2025	By Pivotal bioVenture Partners Fund II, L.P.	Common Stock
Series C Preferred Stock	0			07 Nov 2025	By Pivotal bioVenture Partners Fund I, L.P.	Common Stock
Series Seed Preferred Stock	0			07 Nov 2025	By NFLS Delta III Limited	Common Stock
Series Seed Preferred Stock	0			07 Nov 2025	By Pivotal bioVenture Partners Fund I, L.P.	Common Stock
Series Seed Preferred Stock	0			07 Nov 2025	By Trust	Common Stock

Transactions reported by Robert Lorne Hopfner for Evommune, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.